> ALLIANCE FOR HUMAN RESEARCH PROTECTION
> Promoting Openness, Full Disclosure, and Accountabilityhttp://www.ahrp.organdhttp://ahrp.blogspot.com
>
> FYI
> Another potentially lethal drug has been approved for the treatment of a
> non-life-threatening condition in children.
>
> Amgen's Enbrel is used to treat rheumatoidarthritisin adults and children.
> It is also uses to treat psoriasis in adults but poses serious deadly risks
> of harm.
>
> FDA safety reviewers examined the MedWatch adverse drug event reports and
> found 949 reports of serious complications in children ages 4 to 17 taking
> Enbrel, or etanercept, for psoriasis as well asarthritis.
>
> Among them, 61 reports were for psoriasis patients, according to the
> documents. No deaths were reported, but five patients were hospitalized.
>
> Overall, the FDA found 14 deaths and 76 other life-threatening cases. ...